Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: The restoration of blood-flow following cerebral ischemia incites a series of deleterious cascades that exacerbate neuronal injury. Pharmacologic inhibition of the C3a-receptor ameliorates cerebral injury by attenuating post-ischemic inflammation. Recent reports also implicate C3a in the modulation of tissue repair, suggesting that complement may influence both injury and recovery at later post-ischemic time-points. METHODS: To evaluate the effect of C3a-receptor antagonism on post-ischemic neurogenesis and neurological outcome in the subacute period of stroke, transient focal cerebral ischemia was induced in adult male C57BL/6 mice treated with multiple regimens of a C3a receptor antagonist (C3aRA). RESULTS: Low-dose C3aRA administration during the acute phase of stroke promotes neuroblast proliferation in the subventricular zone at 7 days. Additionally, the C3a receptor is expressed on T-lymphocytes within the ischemic territory at 7 days, and this cellular infiltrate is abrogated by C3aRA administration. Finally, C3aRA treatment confers robust histologic and functional neuroprotection at this delayed time-point. CONCLUSIONS: Targeted complement inhibition through low-dose antagonism of the C3a receptor promotes post-ischemic neuroblast proliferation in the SVZ. Furthermore, C3aRA administration suppresses T-lymphocyte infiltration and improves delayed functional and histologic outcome following reperfused stroke. Post-ischemic complement activation may be pharmacologically manipulated to yield an effective therapy for stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Others have reported that low-dose treatment with the same C3aR antagonist in an ischemia/reperfusion stroke model in C57BL/6 mice resulted in enhanced neurogenesis, histologic and functional neuroprotection, and an anti-inflammatory effect”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,282 · cited 1×
“Alternatively, while an increase in DCX+BrdU+ cells in the hemisphere ipsilateral to an ischemic insult has been described, increased neurogenesis contralateral to an ischemic lesion has also been previously reported [26,27].”
BackgroundComplement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264 · cited 1×
“system that plays a critical role in post-ischemic inflammation [1].”
BackgroundVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon, R. P., & Greenberg, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081011098 · Cited by 1,051 · cited 1×
“Alternatively, while an increase in DCX+BrdU+ cells in the hemisphere ipsilateral to an ischemic insult has been described, increased neurogenesis contralateral to an ischemic lesion has also been previously reported [26,27].”
BackgroundYamashita, T., Ninomiya, M., Hernandez Acosta, P., Garcia-Verdugo, J. M., Sunabori, T., Sakaguchi, M., Adachi, K., Kojima, T., Hirota, Y., Kawase, T., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0149-06.2006 · Cited by 715 · cited 1×
“This likely relates to our use of a 7-day sacrifice time-point, as the process of neuroblast migration from the SVZ to the ischemic territory and subsequent maturation is not complete by this time [25].”
BackgroundBehavioral Tests After Intracerebral Hemorrhage in the Rat
Hua, Y., Schallert, T., Keep, R. F., Wu, J., Hoff, J. T., & Xi, G. (2002) · Stroke · doi:10.1161/01.str.0000032302.91894.0f · Cited by 509 · cited 1×
“Post-stroke sensorimotor dysfunction was also evaluated using the corner-turn test [21].”
MethodSensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse
Bouët, V., Freret, T., Toutain, J., Divoux, D., Boulouard, M., & Schumann-Bard, P. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.006 · Cited by 302 · cited 1×
“[19], according to the formula: LI = (number of right turnsnumber of left turns)/(total number of turns).”
BackgroundBen-Hur, T., Ben-Menachem, O., Furer, V., Einstein, O., Mizrachi-Kol, R., & Grigoriadis, N. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00218-5 · Cited by 284
Complement: a novel factor in basal and ischemia‐induced neurogenesis
Rahpeymai, Y., Hietala, M. A., Wilhelmsson, U., Fotheringham, A., Davies, I., Nilsson, A., Zwirner, J., Wetsel, R. A., Gerard, C., Pekny, M., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601004 · Cited by 279 · cited 9×
“The high-dose cohort received 20 mg/kg per injection, for a total of 40 mg/kg/day [11].”
BackgroundMethodInfluentialReperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic Horizon
Jean, W. C., Spellman, S. R., Nussbaum, E. S., & Low, W. C. (1998) · Neurosurgery · doi:10.1097/00006123-199812000-00076 · Cited by 264
Cited by
Glial Cells: Role of the Immune Response in Ischemic Stroke
Xu, S., Lu, J., Shao, A., Zhang, J. H., & Zhang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00294 · Cited by 601
“In previous studies, the pharmacological inhibition of the C3a-receptor promoted anti-inflammatory neuroprotection, ameliorated neurological deficits, and improved the outcome after stroke (158, 160).”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
“Others have reported that low-dose treatment with the same C3aR antagonist in an ischemia/ reperfusion strokemodel in C57BL/6mice resulted in enhanced neurogenesis, histologic and functional neuroprotection, and an antiinflammatory effect (for example, the absence of T lymphocytes expressing C3aRmigrating into the isc…”
BackgroundImmune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke
Endres, M., Moro, M. A., Nolte, C. H., Dames, C., Buckwalter, M. S., & Meisel, A. (2022) · Circulation Research · doi:10.1161/circresaha.121.319994 · Cited by 340
A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?
Fan, Y.-Y., & Huo, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105080 · Cited by 304
The good, the bad, and the opportunities of the complement system in neurodegenerative disease
Schartz, N. D., & Tenner, A. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02024-8 · Cited by 286
Metadata
- Authors
- Ducruet, A. F., Zacharia, B. E., Sosunov, S. A., Gigante, P. R., Yeh, M. L., Gorski, J. W., Otten, M. L., Hwang, R. Y., DeRosa, P. A., Hickman, Z. L., Sergot, P., & Connolly, E. S.
- Affiliations
- Columbia University (US)
- Corresponding author
- Ducruet, Andrew F.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-26
- Volume
- 7
- Issue
- 6
- Pages
- e38664
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3383680
- OpenAlex
- W2058792228
- Cited by
- 75
- References
- 35
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 10 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 1 · 2015: 8 · 2014: 7 · 2013: 6 · 2012: 2
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- American Heart Association
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS040409)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- complement inhibition, cerebral ischemia, endogenous neurogenesis, subventricular zone, T cell infiltration, post-ischemic inflammation, neuroblast proliferation, stroke treatment
- MeSH terms
- Animals, Anti-Inflammatory Agents, Brain Ischemia, Disease Models, Animal, Inflammation, Male, Mice, Inbred C57BL, Receptors, Complement, T-Lymphocytes, Reperfusion Injury, Complement C3a, Survival Rate, Neuroprotective Agents, Stroke, Mice, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke. https://app.cochat.ai/papers/10.1371/journal.pone.0038664
- The paper
- Ducruet, A. F., Zacharia, B. E., Sosunov, S. A., Gigante, P. R., Yeh, M. L., Gorski, J. W., Otten, M. L., Hwang, R. Y., DeRosa, P. A., Hickman, Z. L., Sergot, P., & Connolly, E. S. (2012). Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke. PLoS ONE. https://doi.org/10.1371/journal.pone.0038664
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.